scholarly journals Pathways from uncertainty to anxiety: An evaluation of a hierarchical model of trait and disorder-specific intolerance of uncertainty on anxiety disorder symptoms

2017 ◽  
Vol 45 ◽  
pp. 72-79 ◽  
Author(s):  
Sarah Shihata ◽  
Peter M. McEvoy ◽  
Barbara A. Mullan
2021 ◽  
Author(s):  
Reza Moloodi ◽  
Fatemeh Mohebban ◽  
Farhad Taremian ◽  
hamid Poursharifi

Abstract Background: Research suggests that Intolerance of Uncertainty is a transdiagnostic risk and maintaining factor in anxiety disorders. The aim of this study was to evaluate the hierarchical model of trait Intolerance of Uncertainty and disorder-specific Intolerance of Uncertainty in symptoms of anxiety disorders in Iranian university students.Methods: Participants (N = 561) completed a battery of questionnaires which assess intolerance of uncertainty, disorder-specific intolerance of uncertainty, metacognition beliefs, fear of negative evaluation, obsessive cognitions, agoraphobic cognitions, obsessive compulsive symptoms, generalized anxiety disorder symptoms, social phobia symptoms, and panic disorder symptoms. Results: Results showed hierarchical model of trait Intolerance of Uncertainty and disorder-specific Intolerance of Uncertainty fit with data. Trait intolerance of uncertainty and disorder-specific intolerance of uncertainty had significant direct and indirect association with various cognitive vulnerabilities and symptoms of anxiety disorders. Conclusion: The findings showed trait intolerance of uncertainty and disorder-specific intolerance of uncertainty have significant contribution to various anxiety disorders. These findings have important implications in conceptualization, prevention and treatment of anxiety disorders.


2020 ◽  
Author(s):  
Jayne Morriss ◽  
Tiffany Bell ◽  
Nicolò Biagi ◽  
Tom Johnstone ◽  
Carien M. van Reekum

AbstractHeightened responding to uncertain threat is associated with anxiety disorder pathology. Here, we sought to determine if individual differences in self-reported intolerance of uncertainty (IU) underlie differential recruitment of neural circuitry during instructed threat of shock (n = 42). During the task, cues signalled uncertain threat of shock (50%) or certain safety from shock. Ratings, skin conductance and functional magnetic resonance imaging was acquired. Overall, participants displayed greater amygdala activation to uncertain threat vs. safe cues, in the absence of an effect of IU. However, we found that high was associated with greater activity in the medial prefrontal cortex and dorsomedial rostral prefrontal cortex to uncertain threat vs safe cues. These findings suggest that, during instructed threat of shock, IU is specifically related, over trait anxiety, to activation in prefrontal cortical regions. Taken together, these findings highlight the potential of self-reported IU in identifying mechanisms that may be related to conscious threat appraisal and anxiety disorder pathology.


2021 ◽  
pp. 1-13 ◽  
Author(s):  
Mehdi Zemestani ◽  
Negar Beheshti ◽  
Farzin Rezaei ◽  
Colin van der Heiden ◽  
Philip C. Kendall

Abstract Given the high prevalence and adverse outcomes associated with generalized anxiety disorder (GAD), development and expansion of effective treatment modalities are important. The present study compared the effectiveness of cognitive behavior therapy targeting intolerance of uncertainty (CBT-IU) and selective serotonin reuptake inhibitors (SSRIs) for treating GAD. A total of 30 Iranian patients with GAD (Mage = 25.16 ± 6.73) were randomised to receive either CBT-IU (n = 15) or SSRI (n = 15). Measures included the Structured Clinical Interview for DSM-5 (SCID-5), Penn State Worry Questionnaire (PSWQ), Why Worry-II (WW-II), Intolerance of Uncertainty Scale (IUS), and Negative Problem Orientation Questionnaire (NPOQ). Repeated measures analysis of variance tested differential treatment outcomes. The results of intention-to-treat (ITT) analysis indicated that although both CBT-IU and SSRI were effective treatments for GAD, CBT-IU produced significantly better results than SSRI at post-treatment. This clinical trial provides preliminary cross-cultural support for the treatment of GAD using CBT-IU, with findings suggesting that this non-medication intervention reduces GAD symptoms.


Sign in / Sign up

Export Citation Format

Share Document